InnoVero and Tasso, Inc. Selected to Deploy Secure, Virtually Painless Anti-Doping Technology at the 2026 Olympic Winter Games

Audio By Carbonatix

COLORADO SPRINGS, Colo. & SEATTLE--(BUSINESS WIRE)--Feb 4, 2026--

Tasso, Inc., a leader in patient-centric blood collection, and InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide, today announced they will supply anti-doping blood collection solutions for the 2026 Olympic Winter Games. The athlete-centric collection system provides a streamlined, user-friendly experience, allowing athletes to provide high-quality blood samples through a process that respects athletes’ time and training priorities, while securing samples critical to protecting clean sport.

“Our innovative approach to anti-doping collections improves the process, making it more comfortable and convenient for athletes and easier for doping control officers. We’re thrilled to continue our track record of bringing this athlete-first innovation to the global stage,” said Gabe Baida, Executive Director of InnoVero.

At the Olympic Games, anti-doping authorities may request blood samples at any time and at any place, underscoring the need for convenient, intuitive sampling technology. At the Beijing 2022 Olympic Winter Games, officials collected more than 3,130 samples from over 1,600 athletes. 1

“Our continued collaboration with InnoVero reflects a shared belief that anti-doping can be both rigorous and athlete-centric,” said Ben Casavant, CEO and Co-Founder of Tasso. “By combining Tasso’s innovative blood collection technology with InnoVero’s anti-doping expertise and solutions, we’re enabling a reliable, secure testing experience that is designed to help athletes focus on performance.”

Athletes and anti-doping organizations alike are embracing alternatives to traditional blood collection methods. Since its introduction to the anti-doping market in 2022, Tasso and InnoVero’s blood collection solutions have seen significant growth in worldwide adoption, including at major sporting events such as the 2024 Paris Olympic Games and 2022 FIFA World Cup.

Trusted globally by more than 30 National Anti-Doping Organizations (NADOs), independent sample collection providers, laboratories, and professional sports leagues, Tasso and InnoVero’s anti-doping solution has been deployed worldwide, with more than 80,000 collection kits distributed since 2021. The system combines Tasso’s virtually painless capillary blood draw with InnoVero’s tamper-evident SAFESystem™ to deliver enhanced sample security, streamlined workflows for doping control officers, and consistent blood volumes for laboratory analysis.

Using dried blood spot (DBS) sampling, the system eliminates the need for a phlebotomist and ensures secure, compliant A and B samples that remain stable and viable without immediate cold-chain requirements, regardless of temperature or climate conditions.

To learn more, visit www.innoveroglobal.com/anti-doping-products.

About InnoVero

InnoVero provides innovation and integrity to the global anti-doping community, through solutions designed to secure global athlete trust. InnoVero’s SAFESystem™ sample collection solutions serve clients globally, The SAFESystem™ features revolutionary security mechanisms that ensure its sample collection bottles are secure, athlete-friendly and tamper-evident, among a suite of features designed to provide seamless and efficient use by athletes, doping control officers and laboratories. For more information about InnoVero, please visit www.innoveroglobal.com.

About Tasso

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260204390160/en/

CONTACT: Media Contacts

InnoVero

info@innoveroglobal.comTasso, Inc.

Media Relations

(206) 822-4186 x1016

media@tassoinc.com

KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON COLORADO

INDUSTRY KEYWORD: HEALTH SPORTS OLYMPICS OTHER SPORTS OTHER HEALTH FITNESS & NUTRITION GENERAL HEALTH

SOURCE: Tasso, Inc.

Copyright Business Wire 2026.

PUB: 02/04/2026 08:00 AM/DISC: 02/04/2026 08:03 AM

http://www.businesswire.com/news/home/20260204390160/en